Sam Joseph Lubner

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Ghassan K. Abou‐Alfa, Teresa Macarulla, Milind Javle et al. · The Lancet Oncology · 2020 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +8

Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With <i>IDH1</i> Mutation

Andrew X. Zhu, Teresa Macarulla, Milind Javle et al. · JAMA Oncology · 2021 · 473 citations · Full text

Medicine, Oncology, Pharmacology +10

CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes

Meghan G. Lubner, Nicholas Stabo, Sam Joseph Lubner et al. · Abdominal Imaging · 2015 · 275 citations

Medicine, Oncology, Radiology +17

Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study

Sam Joseph Lubner, Michelle R. Mahoney, Noelle K. LoConte et al. · Journal of Clinical Oncology · 2010 · 268 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Health Literacy and Health-Related Quality of Life Among a Population-Based Sample of Cancer Patients

Julie Halverson, Ana P. Martínez-Donate, Mari Palta et al. · Journal of Health Communication · 2015 · 155 citations

Medicine, Health Sciences, Oncology +12